How do we identify patients in stages 1 and 2 chronic kidney disease (CKD)? This session reviews the manifestations of CKD stages 1 and 2 and propose ways to slow disease progression while preserving and protecting kidney function.
Continuing Education Instructions and Disclosure Information
Contact hours available until 10/14/2021.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure: Planning Committee: Marijo Johnson - Employee, Fresenius Medical Care
Speaker: Kristin Larson - Employee, United Health Care
There are no other disclosures to declare.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Statement: The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.
Learning Outcome: After completing this learning activity, the learner will describe who should be assessed for CKD stages 1 and 2, the manifestations noted in those stages, and education to slow the progression of the disease process.